Erratum: Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial (The Lancet (2018) 391(10115) (31–40)(S0140673617327149)(10.1016/S0140-6736(17)32714-9));Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

The Lancet

Volumn 391, Issue 10115, 2018, Pages 31-40

  Al Lamee, Rasha ^a,b,i   Thompson, David ^a,b,i   Dehbi, Hakim Moulay ^c   Sen, Sayan ^a,b,i   Tang, Kare ^d,i   Davies, John ^d,i   Keeble, Thomas ^d,i   Mielewczik, Michael ^a   Kaprielian, Raffi ^b,i   Malik, Iqbal S ^b,i   Nijjer, Sukhjinder S ^b,i   Petraco, Ricardo ^a,b,i   Cook, Christopher ^a,b,i   Ahmad, Yousif ^a,b,i   Howard, James ^a,b,i   Baker, Christopher ^b,i   Sharp, Andrew ^e,i   Gerber, Robert ^f,i   Talwar, Suneel ^g,i   Assomull, Ravi ^b,i   Mayet, Jamil ^a,b,i   Wensel, Roland ^a,i   Collier, David ^h   Shun Shin, Matthew ^a,b,i   Thom, Simon A ^a,b,i   Davies, Justin E ^a,b,i   Francis, Darrel P ^a,b,i   Sethi, Amarjit ⁱ   Ramrakha, Punit ⁱ   Foale, Rodney ⁱ   Khamis, Ramzi ⁱ   Hadjiloizou, Nearchos ⁱ   Khan, Masood ⁱ   Kooner, Jaspal ⁱ   Bellamy, Michael ⁱ   Mikhail, Ghada ⁱ   Clifford, Piers ⁱ   O'Kane, Peter ⁱ   Levy, Terry ⁱ   Swallow, Rosie ⁱ   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NHS Foundation Trust   (United Kingdom)

^e ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^f EAST SUSSEX HEALTHCARE NHS TRUST   (United Kingdom)

^g POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; STRESS ECHOCARDIOGRAPHY; UNITED KINGDOM; CLINICAL TRIAL; COMPLICATION; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; EXERCISE TOLERANCE; MIDDLE AGED; TREATMENT OUTCOME;

AGED; ANGINA, STABLE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 85035074993     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)33366-4     Document Type: Erratum

References (32)

1. Gruntzig, A, Transluminal dilatation of coronary-artery stenosis. Lancet, 1, 1978, 263.
2. Boden, WE, O'Rourke, RA, Teo, KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007), 1503–1516.
3. Stergiopoulos, K, Boden, WE, Hartigan, P, et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 174 (2013), 232–240.
4. Spertus, JA, Maron, DJ, Cohen, DJ, et al. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes 6 (2013), 409–418.
5. Windecker, S, Kolh, P, Alfonso, F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 46 (2014), 517–592.
6. Weintraub, WS, Spertus, JA, Kolm, P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359 (2008), 677–687.
7. Wijeysundera, HC, Nallamothu, BK, Krumholz, HM, Tu, JV, Ko, DT, Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med 152 (2010), 370–379.
8. Parisi, AF, Folland, ED, Hartigan, P, A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 236 (1992), 10–16.
9. Ernst, E, Resch, KL, Concept of true and perceived placebo effects. BMJ 311 (1995), 551–553.
10. De Bruyne, B, Fearon, WF, Pijls, NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371 (2014), 1208–1217.
11. Kaptchuk, TJ, Goldman, P, Stone, DA, Stason, WB, Do medical devices have enhanced placebo effects?. J Clin Epidemiol 53 (2000), 786–792.
12. Rothberg, MB, Sivalingam, SK, Kleppel, R, Schweiger, M, Hu, B, Sepucha, KR, Informed decision making for percutaneous coronary intervention for stable coronary disease. JAMA Intern Med 175 (2015), 1199–1206.
13. Thomas, KB, General practice consultations: is there any point in being positive?. Br Med J (Clin Res Ed) 294 (1987), 1200–1202.
14. Schulz, KF, Chalmers, I, Hayes, RJ, Altman, DG, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995), 408–412.
15. Goff, SL, Mazor, KM, Ting, HH, Kleppel, R, Rothberg, MB, How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis. JAMA Intern Med 174 (2014), 1614–1621.
16. Wartolowska, K, Judge, A, Hopewell, S, et al. Use of placebo controls in the evaluation of surgery: systematic review. BMJ, 348, 2014, g3253.
17. Means, G, End, C, Kaul, P, Management of percutaneous coronary intervention complications. Curr Treat Options Cardiovasc Med, 19, 2017, 25.
18. Borer, JS, Fox, K, Jaillon, P, Lerebours, G, for the Ivabradine Investigators Group. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107 (2003), 817–823.
19. Chaitman, BR, Skettino, SL, Parker, JO, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 43 (2004), 1375–1382.
20. Garratt, AM, Hutchinson, A, Russell, I, collaboration with the Network for Evidence-Based Practice in Northern and Yorkshire. The UK version of the Seattle Angina Questionnaire (SAQ-UK): reliability, validity and responsiveness. J Clin Epidemiol 54 (2001), 907–915.
21. Devlin, NJ, Shah, KK, Feng, Y, Mulhern, B, van Hout, B, Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ, 2017 published online Aug 22. DOI:10.1002/hec.3564.
22. Mark, DB, Hlatky, MA, Harrell, FE Jr, Lee, KL, Califf, RM, Pryor, DB, Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 106 (1987), 793–800.
23. Bang, H, Ni, LCE, Assessment of blinding in clinical trials. Control Clin Trials 25 (2004), 143–156.
24. Shun-Shin, MJ, Howard, JP, Francis, DP, Removing the hype from hypertension. BMJ, 348, 2014, g1937.
25. NICE. Stable angina: management. NICE Clinical Guidance CG126. 2016, National Institute for Health and Care Excellence, London.
26. Fihn, SD, Gardin, JM, Abrams, J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60 (2012), e44–164.
27. De Bruyne, B, Pijls, NH, Kalesan, B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367 (2012), 991–1001.
28. Tonino, PA, De Bruyne, B, Pijls, NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 (2009), 213–224.
29. Patel, MR, Calhoon, JH, Dehmer, GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 69 (2017), 2212–2241.
30. Bavry, AA, Kumbhani, DJ, Rassi, AN, Bhatt, DL, Askari, AT, Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 48 (2006), 1319–1325.
31. Barmeyer, A, Meinertz, T, Anaerobic threshold and maximal oxygen uptake in patients with coronary artery disease and stable angina before and after percutaneous transluminal coronary angioplasty. Cardiology 98 (2002), 127–131.
32. Williams, SG, Stables, RH, Wright, DJ, Taylor, S, Thompson, D, Tan, LB, Relationship of serum cardiac markers following successful percutaneous coronary intervention and subsequent exercise capacity in patients with chronic stable angina: a pilot study. Cardiology 103 (2005), 63–67.